These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8204800)

  • 21. Nitroglycerin induces late preconditioning against arrhythmias but not stunning in conscious sheep.
    Lascano EC; Valle HF; Negroni JA
    Scand Cardiovasc J; 2007 Jun; 41(3):160-6. PubMed ID: 17487765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning.
    Canyon SJ; Dobson GP
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
    Zhang JH; Chen ZW; Wu Z
    Can J Physiol Pharmacol; 2008 Mar; 86(3):131-8. PubMed ID: 18418440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity.
    Ii M; Nishimura H; Iwakura A; Wecker A; Eaton E; Asahara T; Losordo DW
    Circulation; 2005 Mar; 111(9):1114-20. PubMed ID: 15723985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-conditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway.
    Penna C; Cappello S; Mancardi D; Raimondo S; Rastaldo R; Gattullo D; Losano G; Pagliaro P
    Basic Res Cardiol; 2006 Mar; 101(2):168-79. PubMed ID: 16132172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bradykinin as an endogenous myocardial protective substance with particular reference to ischemic preconditioning--a brief review of the evidence.
    Parratt JR; Vegh A; Papp JG
    Can J Physiol Pharmacol; 1995 Jul; 73(7):837-42. PubMed ID: 8846418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart.
    Hearse DJ; Ferrari R; Sutherland FJ
    J Mol Cell Cardiol; 1999 Nov; 31(11):1961-73. PubMed ID: 10591023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ischaemic preconditioning: from molecular characterisation to clinical application--part II.
    Riksen NP; Smits P; Rongen GA
    Neth J Med; 2004 Dec; 62(11):409-23. PubMed ID: 15685892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological preconditioning by levosimendan is mediated by inducible nitric oxide synthase and mitochondrial KATP channel activation in the in vivo anesthetized rabbit heart model.
    Das B; Sarkar C
    Vascul Pharmacol; 2007 Oct; 47(4):248-56. PubMed ID: 17728191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotection by ischemic and nonischemic myocardial stress and ischemia in remote organs. Implications for the concept of ischemic preconditioning.
    Verdouw PD; Gho BC; Koning MM; Schoemaker RG; Duncker DJ
    Ann N Y Acad Sci; 1996 Sep; 793():27-42. PubMed ID: 8906153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats.
    Vegh A; Komori S; Szekeres L; Parratt JR
    Cardiovasc Res; 1992 May; 26(5):487-95. PubMed ID: 1446318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia.
    Li YW; Whittaker P; Kloner RA
    Am Heart J; 1992 Feb; 123(2):346-53. PubMed ID: 1736569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation.
    Parratt JR
    Trends Pharmacol Sci; 1994 Jan; 15(1):19-25. PubMed ID: 8140654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pronounced antiarrhythmic effects of ischaemic preconditioning--are there possibilities for pharmacological exploitation?
    Parratt J; Vegh A; Papp JG
    Pharmacol Res; 1995; 31(3-4):225-34. PubMed ID: 7630863
    [No Abstract]   [Full Text] [Related]  

  • 36. Bradykinin and endothelial-cardiac myocyte interactions in ischemic preconditioning.
    Parratt JR; Vegh A; Zeitlin IJ; Ahmad M; Oldroyd K; Kaszala K; Papp JG
    Am J Cardiol; 1997 Aug; 80(3A):124A-131A. PubMed ID: 9293965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ischemic preconditioning against arrhythmias: an anti-arrhythmic or an anti-ischemic phenomenon?
    Lawson CS; Hearse DJ
    Ann N Y Acad Sci; 1994 Jun; 723():138-57. PubMed ID: 8030861
    [No Abstract]   [Full Text] [Related]  

  • 38. A common mechanism in the protective effects of preconditioning, cardiac pacing and physical exercise against ischemia and reperfusion-induced arrhythmias.
    Végh A; Parratt JR
    Exp Clin Cardiol; 2005; 10(3):200-5. PubMed ID: 19641688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification by bradykinin B2 receptor blockade of protection by pacing against ischaemia-induced arrhythmias.
    Kaszala K; Végh A; Papp JG; Parratt JR
    Eur J Pharmacol; 1997 Jun; 328(1):51-60. PubMed ID: 9203568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pronounced antiarrhythmic effects of preconditioning in anaesthetized dogs: is adenosine involved?
    Vegh A; Papp JG; Parratt JR
    J Mol Cell Cardiol; 1995 Jan; 27(1):349-56. PubMed ID: 7760356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.